AstraZeneca in partnering talks for Alzheimer’s drug
[Reuters – UK Focus] – * AstraZeneca (NYSE: AZN – news) ready to start Phase III tests on BACE drug (Adds quote, details on competitors, background) LONDON, May 7 (Reuters) – AstraZeneca, fighting a $106 billion bid approach from Pfizer (NYSE: PFE – news moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view […]